EVOVSMREO• 3 Months (Normalized)
EVO vs MREO (Evotec SE vs Mereo BioPharma Group plc)
Showing Closing Date Range from Jun, 13 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
EVO Performance $1.73
-38.21%
Evotec SE
Normalized Baseline0.00%
MREO Performance $0.28
-5.41%
Mereo BioPharma Group plc
Normalized Baseline0.00%
Alpha Spread Margin MREO LEADS
-32.8%
MREO outperforming by 32.80%
EVOMREO
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
EVO MREO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | EVO Price | EVO Gain (%) | MREO Price | MREO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.73 | -38.21% | $0.28 | -5.41% | -32.80% |
| Sep 10, 2026 | $1.77 | -36.79% | $0.25 | -17.23% | -19.56% |
| Sep 09, 2026 | $1.81 | -35.36% | $0.24 | -17.91% | -17.45% |
| Sep 08, 2026 | $1.82 | -35.00% | $0.26 | -13.85% | -21.15% |
| Sep 04, 2026 | $1.86 | -33.57% | $0.25 | -15.54% | -18.03% |
| Sep 03, 2026 | $1.90 | -32.14% | $0.27 | -8.11% | -24.03% |
| Sep 02, 2026 | $1.90 | -32.14% | $0.27 | -9.80% | -22.34% |
| Sep 01, 2026 | $1.80 | -35.71% | $0.28 | -6.42% | -29.29% |
| Aug 31, 2026 | $1.88 | -32.86% | $0.27 | -9.80% | -23.06% |
| Aug 28, 2026 | $1.91 | -31.79% | $0.25 | -14.53% | -17.26% |
| Aug 27, 2026 | $1.97 | -29.64% | $0.27 | -8.11% | -21.53% |
| Aug 26, 2026 | $1.95 | -30.36% | $0.28 | -6.08% | -24.28% |
| Aug 25, 2026 | $1.89 | -32.50% | $0.28 | -4.73% | -27.77% |
| Aug 24, 2026 | $1.89 | -32.50% | $0.29 | -2.03% | -30.47% |
| Aug 21, 2026 | $1.93 | -31.07% | $0.29 | -2.03% | -29.04% |
Page 1 of 5